LC-MS-Based Metabonomics Study of Yangxin Tongmaifang Against Coronary Heart Disease Differentiated into Blood Stasis Syndrome
10.13422/j.cnki.syfjx.20211318
- VernacularTitle:基于LC-MS技术的养心通脉方干预冠心病血瘀证的代谢组学分析
- Author:
Man-li ZHOU
1
;
Yun-feng YU
1
;
Xiao-xin LUO
1
;
Xia-hui ZHOU
1
;
Yi-fan ZHANG
1
;
Yan-zhen ZHAO
1
;
Wei-xiong JIAN
1
Author Information
1. College of Traditional Chinese Medicine（TCM），Hunan University of Chinese Medicine， Changsha 410208，China
- Publication Type:Research Article
- Keywords:
Yangxin Tongmaifang（YXTM）;
heart blood stasis syndrome;
myocardial tissue;
biomarker;
metabolic pathway
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2021;27(22):139-146
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the effect of Yangxin Tongmaifang （YXTM） on endogenous metabolites in the myocardial tissue of rats with coronary heart disease due to blood stasis based on the metabolomics approach， and to explore its mechanism in the treatment of heart blood stasis syndrome. Method:A rat model of chronic myocardial ischemia due to heart blood stasis was established via the high-fat diet combined with intragastric administration of vitamin D3 and subcutaneous injection of isoproterenol （ISO）， followed by the intervention with YXTM. The metabolites in the myocardial tissues of rats in the normal group （n=8）， model group （n=8）， and YXTM group （n=8） were detected by ultra-high performance liquid chromatography coupled to high resolution mass spectrometry. The high-throughput metabolomics data were then subjected to multivariate statistical analysis using SIMCA 14.1， and the related metabolic pathways were analyzed with MetaboAnalyst. Result:The myocardial sample points of rats in the three groups were located in different areas of the elliptical confidence interval. The normal group and the model group were completely separated. There existed some crossovers and overlaps between the YXTM group and the normal group. The heart blood stasis syndrome model was proved successfully replicated from the perspective of metabolic profiling， and YXTM had the potential to promote the body to return to a normal state. After the intervention with YXTM， six differential metabolites changed significantly. Such metabolic pathways as valine， leucine， and isoleucine biosynthesis， pantothenate and coenzyme A （CoA） biosynthesis， valine， leucine， and isoleucine degradation， biosynthesis of aminoacyl-transfer RNA synthetases， and purine metabolism were involved. Conclusion:The therapeutic effect of YXTM on heart blood stasis syndrome in rats is related to the improved levels of myocardial endogenous metabolites， and its mechanism involves phospholipid metabolism， amino acid metabolism， energy metabolism， inflammatory response， and platelet activation and aggregation.
